Rationale and design of the EMBRACE STEMI Study: A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction

Published 2013 View Full Article

Authors

Keywords

Journal

AMERICAN HEART JOURNAL

Volume 165, Issue 4, Pages 509-514.e7

Publisher

Elsevier BV

Online

2013-02-16

DOI

10.1016/j.ahj.2012.12.008

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

AMERICAN HEART JOURNAL

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Add your recorded webinar

Become a Peeref-certified reviewer